Compare Mesoblast Limited (MESO) vs Tesla, Inc. (TSLA) Price & Performance

Mesoblast LimitedTrade

Tesla, Inc.Trade

Price performance (Past 24H)

Key statistics

Mesoblast Limited vs Tesla, Inc. — how do they compare? Mesoblast Limited trades at $16.38 (market cap $2.17B), while Tesla, Inc. trades at $379.19 (market cap $1.39T). The key difference: Tesla, Inc. is far larger — about 640.6× Mesoblast Limited's market cap. Which is the better fit depends on your goals.

	MESO	TSLA
Market Cap	$2.17B	$1.39T
Sector	Technology	Consumer Cyclical
52-Week High	$20.96	$489.88
52-Week Low	$12.88	$302.63
Enterprise Value	$2.17B	$1.36T

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Mesoblast Limited

No Aura AI signal available yet.

Tesla, Inc.

Tesla (TSLA) trades at $378.88, down 0.51% with a bearish technical outlook. The stock faces valuation concerns with a P/E of 339 and declining profitability margins, though recent earnings beat expectations. Cash flow remains positive despite heavy capital investments. European regulatory approval for driver-assistance software and German sales growth provide optimism, but competition and slowing auto business present challenges.

Tesla's outlook balances innovation potential against execution risks. The stock offers growth exposure to AI and autonomy but carries premium valuation and competitive pressures. Near-term catalysts include Q2 earnings and robotaxi developments, while margin compression and market sentiment shifts represent key investor risks.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MESO

View details →

TSLA

Roundhill Magnificent Seven ETF offers equal exposure to top 7 mega-cap tech stocks but with higher risk and cost.24/7 Wall Street · 8 hours agoNeutral Northrop Grumman CEO hints space robots could be weaponized, leaving decision to US government.Forbes · 8 hours agoBullish Options traders expect Tesla's biggest post-earnings move in a year, with a 5.76% price swing implied.CNBC · 9 hours agoNeutral View details →

About Mesoblast Limited

Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.

About Tesla, Inc.

Tesla Inc. designs, manufactures, and sells high-performance electric vehicles and electric vehicle powertrain components. The Company owns its sales and service network and sells electric power train components to other automobile manufacturers. Tesla serves customers worldwide.